Table 3.
Most Frequently Used hESC Lines
| hESC Line | hPSCreg Nomenclature | 2008–2010 |
2011–2013 |
2014–2016 |
Total (2008–2016) |
||||
|---|---|---|---|---|---|---|---|---|---|
| Number of Papers | % of Papers | Number of Papers | % of Papers | Number of Papers | % of Papers | Number of Papers | % of Papers | ||
| H9∗ | WAe009-A | 495 | 41.5 | 847 | 48.4 | 860 | 47.8 | 2202 | 46.4 |
| H1∗ | WAe001-A | 289 | 26.9 | 411 | 23.5 | 414 | 23.0 | 1114 | 23.5 |
| H7∗ | WAe007-A | 93 | 8.7 | 136 | 7.8 | 122 | 6.8 | 351 | 7.4 |
| HES-3∗ | ESIBIe003-A | 80 | 7.4 | 104 | 5.9 | 103 | 5.7 | 287 | 6.0 |
| HUES9 | HVRDe009-A | 60 | 5.6 | 64 | 3.7 | 54 | 3.0 | 178 | 3.8 |
| BG01∗ | VIACe001-A | 81 | 7.5 | 60 | 3.4 | 31 | 1.7 | 172 | 3.6 |
| HES-2∗ | ESIBIe002-A | 60 | 5.6 | 67 | 3.8 | 45 | 2.5 | 172 | 3.6 |
| KhES-1 | KUIMSe001-A | 37 | 3.4 | 52 | 3.0 | 45 | 2.5 | 134 | 2.8 |
| HUES7 | HVRDe007-A | 31 | 2.9 | 35 | 2.0 | 34 | 1.9 | 100 | 2.1 |
| KhES-3 | KUIMSe003-A | 24 | 2.2 | 47 | 2.7 | 25 | 1.4 | 96 | 2.0 |
| HSF-6∗ | UCSFe002-A | 44 | 4.1 | 31 | 1.8 | 17 | 0.9 | 92 | 1.9 |
| H14∗ | WAe014-A | 27 | 2.5 | 35 | 2.0 | 23 | 1.3 | 85 | 1.8 |
| HUES6 | HVRDe006-A | 16 | 1.5 | 33 | 1.9 | 26 | 1.4 | 75 | 1.6 |
| HUES1 | HVRDe001-A | 28 | 2.6 | 22 | 1.3 | 17 | 0.9 | 67 | 1.4 |
| HUES3 | HVRDe003-A | 23 | 2.1 | 26 | 1.5 | 17 | 0.9 | 66 | 1.4 |
| HUES8 | HVRDe008-A | 17 | 1.6 | 20 | 1.1 | 28 | 1.6 | 65 | 1.4 |
| HS181 | KIe001-A | 29 | 2.7 | 20 | 1.1 | 12 | 0.7 | 61 | 1.3 |
| HSF-1∗ | UCSFe003-A | 25 | 2.3 | 23 | 1.3 | 8 | 0.4 | 56 | 1.2 |
| MEL-1 | SCSe001-A | 12 | 1.1 | 24 | 1.4 | 18 | 1.0 | 54 | 1.1 |
| CA1 | MSHRIe001-A | 16 | 1.5 | 24 | 1.4 | 10 | 0.6 | 50 | 1.1 |
| H13∗ | WAe013-A | 17 | 1.6 | 23 | 1.3 | 8 | 0.4 | 48 | 1.0 |
Shown are the numbers of papers that report on experimental use of the particular hESC line. The percentage values present the share of publications in the total number of hESC research papers in the given period. Only results for cell lines that were used in at least 1% of papers published from 2008 to 2016 are shown. Please note that in many studies more than one hESC line was used. Sublines and (genetically modified) derivatives were allocated to the respective parental hESC line. hESC lines that were derived before August 22nd 2001 are marked with asterisks. hPSCreg, Human Pluripotent Stem Cell Registry of the European Union.